Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Sex Transm Dis ; 26(2): 115-8, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10029987

RESUMO

BACKGROUND AND OBJECTIVES: A survey was conducted to determine the sexual behavior practices and prevalence of HIV-1, HTLV-I/II, and T. pallidum infections among unlicensed female sex workers (FSWs) in Lima, Peru. GOAL OF THIS STUDY: To assess the role of unlicensed FSWs as a potential source of retroviral and T. pallidum infection. STUDY DESIGN: Female sex workers from 15 brothels were enrolled. Sera samples were obtained and tested for antibodies to HIV-1, HTLV-I, and Treponema pallidum. RESULTS: Of 158 FSWs studied, all were negative for HIV-1, 6 were positive for HTLV-I, and 5 were positive for Treponema pallidum. Of their male clients, 75% used condoms, whereas only 3% reported condom use with their steady partners. When condoms were always used by clients, the history of a sexually transmitted disease was significantly reduced (p < 0.01), and the prevalence of HTLV-I (p < 0.05) and syphilis was lower among these workers. CONCLUSION: Data suggested that the low rate of sexually transmitted diseases among FSWs reflected the high rate of condom use by their male clients.


PIP: A survey was conducted to determine the prevalence of HIV-I, human T cell leukemia virus I and II (HTLV-I/II), and Treponema pallidum infection and the associated risk factors for the transmission of these sexually transmitted diseases (STDs) among unlicensed female sex workers (FSWs) in Lima, Peru, to further define their role as a potential source of infection. Unlicensed FSWs from 15 brothels were enrolled in this study from March to June 1994. Serum samples were collected and tested for antibodies to HIV-I, HTLV-I, HTLV-II, and Treponema pallidum. Results revealed that of the 158 FSWs studied, all were negative for HIV-I; 6 were positive for HTLV-I, and 5 had T. pallidum antibodies. Of their male clients, 75% had used condoms for the past 6 months, whereas only 3% reported condom use with their steady partners. Among the workers who stated that condoms were always used, the frequency of a history of STDs, including genital ulcers and inguinal adenopathies, was lower compared to occasional users. Similarly, the prevalence of HTLV-I infection and syphilis was lower among these workers. In conclusion, the study results suggested that the low rate of STDs among FSWs reflected a high rate of condom use.


Assuntos
Infecções por Deltaretrovirus/epidemiologia , Infecções por HIV/epidemiologia , Trabalho Sexual/estatística & dados numéricos , Comportamento Sexual/estatística & dados numéricos , Sífilis/epidemiologia , Adulto , Anticorpos Antivirais/sangue , Preservativos/estatística & dados numéricos , Infecções por Deltaretrovirus/imunologia , Feminino , Anticorpos Anti-HIV/sangue , Infecções por HIV/imunologia , HIV-1/imunologia , Vírus Linfotrópico T Tipo 1 Humano/imunologia , Vírus Linfotrópico T Tipo 2 Humano/imunologia , Humanos , Masculino , Peru/epidemiologia , Prevalência , Treponema pallidum/imunologia
2.
J Pediatr ; 126(6): 882-6, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7776088

RESUMO

Surveillance was conducted during February and March 1991 in the pediatric emergency department of Cayetano Heredia Hospital, Lima, Peru, to contrast the characteristics of children with epidemic cholera with those of children with noncholera-associated diarrhea. Among 626 patients 14 years of age or younger, Vibrio cholerae O1 was isolated from stool specimens of 310 patients (49%), more commonly from children older than 24 months of age (66%; p < 0.0001) than from younger children. Cholera was clinically characterized by a more sudden onset; watery diarrhea; and associated abdominal pain, muscle cramps, and vomiting, which led to more severe dehydration and hospitalization more often than in noncholera cases. Only one patient with cholera died, for a case-fatality rate of 3.2 deaths per 1000 persons. Nonpotable water and uncooked foods were identified as probable vehicles for V. cholerae. The frequency of diarrhea among relatives of patients with cholera suggested intrafamily transmission. This study of epidemic cholera describes the clinical features and the risk factors for acquisition of the infection, and points out the low case-fatality rate with prompt and appropriate treatment.


Assuntos
Cólera/etiologia , Cólera/fisiopatologia , Dor Abdominal , Adolescente , Fatores Etários , Criança , Pré-Escolar , Cólera/transmissão , Desidratação/fisiopatologia , Diarreia/fisiopatologia , Família , Humanos , Lactente , Fatores de Risco , Vômito
3.
Surgery ; 116(1): 28-35, 1994 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8023265

RESUMO

BACKGROUND: A prospective, randomized, single-blind study evaluated the efficacy and safety of clindamycin plus amikacin versus clindamycin plus aztreonam (Cl-Az) in treating intraabdominal infections in adults. METHODS: Patients were treated intravenously for 7 to 10 days, clindamycin 900 mg plus amikacin 5.0 mg/kg three times a day or clindamycin 900 mg plus aztreonam 2.0 gm three times a day. All 67 patients enrolled were evaluated for safety and 31 in each group for clinical and microbiologic response. Both groups were similar in initial diagnosis, perforated appendicitis or intraabdominal abscess. In each group 24 patients (77%) were admitted in serious condition and three (10%) in critical condition. Twenty-five patients (80.6%) in each group had aerobic and anaerobic pathogens; the remainder had either aerobic or anaerobic pathogens. RESULTS: On therapy completion, clinical and bacteriologic responses were as follows: clindamycin plus amikacin group, 26 (84%) cured, 3 (9.7%) improved, and 2 (6.3%) failed; Cl-Az group, 25 (80.7%) cured, 6 (19.3%) improved, and 0 failed. Rapid temperature decrease occurred in Cl-Az group (p = 0.007). Forty-one mild adverse medical events reported were evenly distributed, but no patients were removed as a result. CONCLUSIONS: Both combinations were highly effective in managing intraabdominal sepsis. Clindamycin aztreonam showed a slight advantage because of absence of renal toxicity and shorter time to apyrexia.


Assuntos
Abdome , Abscesso/tratamento farmacológico , Amicacina/uso terapêutico , Apendicite/tratamento farmacológico , Aztreonam/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Clindamicina/uso terapêutico , Adulto , Amicacina/administração & dosagem , Apendicite/microbiologia , Aztreonam/administração & dosagem , Clindamicina/administração & dosagem , Quimioterapia Combinada , Feminino , Humanos , Infusões Intravenosas , Perfuração Intestinal/tratamento farmacológico , Perfuração Intestinal/microbiologia , Masculino , Estudos Prospectivos , Método Simples-Cego
4.
Acta Paediatr Suppl ; 381: 32-8, 1992 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1421938

RESUMO

In a longitudinal study of acute and persistent diarrhea in 677 children less than three years old in a peri-urban community of Lima, Perú, during 27 months of surveillance, stools were cultured at the beginning of each diarrheal episode and on each subsequent week of illness. Analyzing stool cultures only from children who had not received antibiotic treatment in the 48 h prior to the culture, no association was found between any enteropathogen and persistent diarrhea. We did not find any increase in mixed infections in persistent diarrhea episodes as compared with acute diarrhea, controlling for age, season and anthropometric status. The isolation rate for any given enteropathogen was similar during the first, second, third or later week of illness, but when the presence of a specific enteropathogen was sought in sequential stools within a single episode, no evidence of persistent infection was found. This study shows that in developing countries with a high incidence of diarrheal diseases frequent re-infections with enteropathogens prevalent in the population are one reason for prolonged illnesses. Host factors that increase susceptibility to infection or decrease recovery from illness may also play a role. Further studies of these factors, such as micronutrient deficiencies, are needed to identify a public health intervention to control persistent diarrhea, a condition associated with mortality in many developing countries.


Assuntos
Bactérias/isolamento & purificação , Diarreia/microbiologia , Fezes/microbiologia , Doença Aguda , Animais , Pré-Escolar , Doença Crônica , Cryptosporidium/isolamento & purificação , Diarreia/parasitologia , Diarreia Infantil/microbiologia , Diarreia Infantil/parasitologia , Giardia/isolamento & purificação , Humanos , Lactente , Estudos Longitudinais , Peru , População Suburbana
5.
J Clin Microbiol ; 29(6): 1151-6, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1864933

RESUMO

Rectal swabs from 391 infants less than 18 months of age who were hospitalized with acute diarrhea and from 138 similarly aged healthy infants were examined for the etiologic agents of diarrhea. Aeromonas spp. were recovered from 205 of 391 (52.4%) diarrheic patients, whereas they were recovered from 12 of 138 (8.7%) controls (P less than 10(-11). Among the 205 Aeromonas-positive diarrheic patients, 118 (57.6%) were found to be coinfected with other common enteropathogens. Of the 164 Aeromonas-positive initial diarrheic specimens, 82 (50.0%) had one or more other enteropathogens present; 30 patients were coinfected with rotavirus, 20 with enterotoxigenic Escherichia coli, 16 with Campylobacter spp., 14 with Shigella spp., 13 with enteropathogenic E. coli, 4 with Vibrio spp., 1 with Salmonella spp., and 1 with Plesiomonas spp. of Aeromonas strains from cases compared with that from controls supports an etiologic role for this organism. However, frequent concomitant infections with other well-recognized enteropathogens and a lack of disease correlation with common Aeromonas phenotypes suggest that only a subset of Aeromonas strains may be diarrhea causing and that such strains may be common to several of the existing species.


Assuntos
Aeromonas , Infecções Bacterianas/microbiologia , Diarreia/microbiologia , Aeromonas/isolamento & purificação , Aeromonas/metabolismo , Aeromonas/patogenicidade , Infecções Bacterianas/epidemiologia , Diarreia/epidemiologia , Feminino , Humanos , Lactente , Masculino , Peru/epidemiologia , Fenótipo , Estações do Ano , Virulência
6.
J Infect Dis ; 163(3): 495-502, 1991 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1995722

RESUMO

Because the causes of measles-associated diarrhea are not well known, 0- to 5-year-old children presenting to the hospital with measles-associated diarrhea (cases, n = 77) or acute diarrhea only (controls, n = 77) were compared. Growth and diarrheal morbidity were evaluated for 1 month after acute illness. Campylobacter jejuni was more frequently isolated from cases (31%) than controls (16%; P = .03). Rotavirus was absent in all cases versus 28% of controls (P less than .001). Incidence density for new episodes of diarrhea was significantly greater in cases (6.5 vs. 4.1; odds ratio, 1.6; confidence intervals, 1.09-2.34; P = .01), as was duration of episodes (3 vs. 2 days, P = .02). Both groups showed similar positive cumulative percentage weight gains throughout follow-up. These data support the theory of measles as a risk factor for developing diarrhea. The bacteriologic and virologic findings may reflect the immunologic response of the host to measles infection.


Assuntos
Diarreia/microbiologia , Crescimento , Sarampo/complicações , Doença Aguda , Antropometria , Estudos de Casos e Controles , Pré-Escolar , Diarreia/parasitologia , Diarreia/fisiopatologia , Feminino , Hospitalização , Humanos , Lactente , Masculino , Sarampo/fisiopatologia , Peru
8.
J Clin Microbiol ; 28(5): 886-9, 1990 May.
Artigo em Inglês | MEDLINE | ID: mdl-2351731

RESUMO

Eleven strains of Plesiomonas shigelloides isolated from 10 Peruvian children with diarrhea were examined. All the strains were resistant to two or more antibiotics, most commonly ampicillin, gentamicin, erythromycin, kanamycin, and streptomycin. The strains were all negative in the Sereny and cell culture assays used to test for enteroinvasiveness. One strain showed cytotoxic activity on Vero cells. The strains showed no antigenic relationship with Shigella organisms. Both bioassays and enzyme-linked immunosorbent assays used for detection of Escherichia coli enterotoxins were negative. Nucleic acid probes for such toxins likewise gave negative results. The strains all possessed a large (approximately 200-megadalton) plasmid in addition to one or more other plasmids. Several different plasmid profiles were observed among these 11 P. shigelloides strains, indicating that the isolates were not acquired from a common source or from a single bacterial clone.


Assuntos
Diarreia/microbiologia , Vibrionaceae/isolamento & purificação , Criança , Sondas de DNA , Diarreia/etiologia , Enterotoxinas/análise , Fezes/microbiologia , Humanos , Peru , Plasmídeos , Vibrionaceae/genética , Vibrionaceae/patogenicidade
9.
Antimicrob Agents Chemother ; 33(7): 1101-4, 1989 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2675757

RESUMO

Shigellae have been shown to be highly susceptible to new quinolone agents, with average MICs for 90% of isolates of less than 0.1 microgram/ml. Because these agents also reach high concentrations in the stool after a single dose, the effectiveness of a single 800-mg dose of norfloxacin and of 5-day treatment with trimethoprim-sulfamethoxazole (TMP-SMX) were compared in a randomized trial. Patients with clinical dysentery received one of these treatment regimens, and clinical data and follow-up culture results were analyzed for patients whose stool culture on presentation grew shigellae. When 55 patients with shigellosis (26 treated with TMP-SMX, 29 treated with norfloxacin) whose bacterial isolates were susceptible to the antibiotic given were compared by treatment group, no significant differences were seen in days of illness (mean, 2.5 +/- 0.65 days with TMP-SMX and 2.0 +/- 0.47 days with norfloxacin; P = 0.200) or number of unformed stools after starting treatment (mean, 9.7 +/- 2.37 stools with TMP-SMX and 7.6 +/- 3.19 stools with norfloxacin; P = 0.312). Resistance in vitro to TMP-SMX was seen in 15% of Shigella isolates, whereas none was resistant to norfloxacin. Bacteriologic failure was found in 1 patient among 24 receiving TMP-SMX and in none of 25 patients receiving norfloxacin. One single dose of norfloxacin was as effective as 5 days of treatment with TMP-SMX in these adults with shigellosis.


Assuntos
Disenteria Bacilar/tratamento farmacológico , Norfloxacino/uso terapêutico , Sulfametoxazol/uso terapêutico , Trimetoprima/uso terapêutico , Adulto , Ensaios Clínicos como Assunto , Diarreia/microbiologia , Combinação de Medicamentos/uso terapêutico , Disenteria Bacilar/microbiologia , Fezes/microbiologia , Humanos , Distribuição Aleatória , Combinação Trimetoprima e Sulfametoxazol
10.
Scand J Gastroenterol Suppl ; 169: 19-23, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2694339

RESUMO

Seventy-one adults who were hospitalized between March 1985 and March 1987 were entered into a randomized, double-blind study to compare the efficacy and safety of furazolidone and chloramphenicol in therapy for typhoid fever. Patients received chloramphenicol capsules (total daily dosage, 2 g) plus placebo tablets for furazolidone tablets (total daily dosage, 800 mg) plus placebo capsules for 14 days. Seven patients were excluded from the analysis of efficacy because blood, bile, or bone marrow cultures at admission failed to demonstrate the presence of Salmonella typhi. Four additional patients were excluded because of intercurrent illness or failure to return for follow-up visits. Cure was achieved in 31 (97%) of 32 chloramphenicol recipients and 24 (86%) of 28 furazolidone recipients. In the chloramphenicol group, one patient experienced moderate sideroblastic anemia, and another experienced moderate neutropenia. Both adverse reactions resolved spontaneously within 7 days. Mild gastritis was reported by two patients who received furazolidone and one who received chloramphenicol. This study has demonstrated that furazolidone is an effective and safe alternative to chloramphenicol for the treatment of typhoid fever in adults.


Assuntos
Cloranfenicol/uso terapêutico , Furazolidona/uso terapêutico , Febre Tifoide/tratamento farmacológico , Adulto , Método Duplo-Cego , Feminino , Humanos , Masculino , Ensaios Clínicos Controlados Aleatórios como Assunto
13.
J Pediatr ; 109(2): 355-60, 1986 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-3488385

RESUMO

To evaluate the efficacy of early treatment with erythromycin on the duration of fecal excretion and of diarrhea associated with Campylobacter jejuni, 170 patients, age 3 to 60 months, were randomly assigned in a double-blind fashion to receive either erythromycin ethyl succinate or placebo immediately after being seen at Cayetano Heredia Hospital because of acute dysentery. The groups' pretreatment characteristics were comparable. Of the 30 patients with stools positive for C. jejuni, 12 were in the placebo group and 16 in the treatment group. After 2 days of treatment, none of the patients in the placebo group and 36% of those in the erythromycin group had normal stools (P less than 0.05). After 5 days of treatment, 50% of the patients in the placebo group and 93% of those in the erythromycin group had normal stools (P less than 0.02). Fecal excretion of the organism continued significantly longer in the placebo group (P less than 0.01). There were no treatment failures in the treatment group compared with five (42%) in the placebo group (P less than 0.01). Thus, early administration of erythromycin significantly reduced the duration of both diarrhea and fecal excretion of the organism in infants and children with acute dysentery associated with C. jejuni.


Assuntos
Infecções por Campylobacter/tratamento farmacológico , Disenteria/tratamento farmacológico , Eritromicina/análogos & derivados , Campylobacter fetus/isolamento & purificação , Pré-Escolar , Método Duplo-Cego , Disenteria/etiologia , Eritromicina/uso terapêutico , Etilsuccinato de Eritromicina , Fezes/microbiologia , Feminino , Seguimentos , Humanos , Lactente , Masculino , Placebos , Distribuição Aleatória , Fatores de Tempo
14.
J Pediatr ; 108(1): 55-60, 1986 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3003317

RESUMO

In a double-blind, randomized trial, we compared the efficacy of bicarbonate-containing oral rehydration solution vs citrate-containing solution in the treatment of infantile diarrheal dehydration and acidosis. Ninety-seven infants 3 to 24 months of age were entered in the study; 49 received bicarbonate-containing solution and 48 citrate-containing solution. The two groups were similar in all respects at the beginning of the study. Oral rehydration was successful (i.e., no intravenously administered fluids were required) in 85% of study patients; the success rate was similar in both treatment groups. Serum total CO2 concentration increased in a similar fashion in both groups, reaching near normal values at 48 hours after admission. We conclude that sodium citrate can be substituted for sodium bicarbonate in the formulation of the orally administered rehydration solution recommended by the World Health Organization for treatment of diarrheal dehydration in infants.


Assuntos
Bicarbonatos/uso terapêutico , Citratos/uso terapêutico , Diarreia Infantil/terapia , Hidratação , Sódio/uso terapêutico , Dióxido de Carbono/sangue , Pré-Escolar , Ácido Cítrico , Ensaios Clínicos como Assunto , Diarreia Infantil/sangue , Método Duplo-Cego , Feminino , Hematócrito , Humanos , Lactente , Masculino , Bicarbonato de Sódio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA